Potential risks of recombinant DNA tests
Borst, P.
Nederlands Tijdschrift Voor Geneeskunde 122(46): 1801-1808
1978
ISSN/ISBN: 0028-2162 PMID: 360083 Document Number: 132223
Document emailed within 1 workday
Related Documents
Kukin, M. 1978: Research with recombinant DNA: potential risks, potential benefits, and ethical considerations New York State Journal of Medicine 78(2): 226-235Knapik, J.J. 2015: Extreme Conditioning Programs: Potential Benefits and Potential Risks Journal of Special Operations Medicine: a Peer Reviewed Journal for Sof Medical Professionals 15(3): 108-113
Rafii, F.; Crawford, D.L.; Bleakley, B.H.; Wang, Z. 1988: Assessing the risks of releasing recombinant Streptomyces in soil Microbiological Sciences 5(12): 358-362
Mortensen, H. 1983: Potential risks should be reduced as best as possible Sygeplejersken 83(11): 26
Dalbøge, H.; Madsen, B.; Jørgensen, K.D.; Carlsen, S. 1988: Assessment of risks in connection with use of a recombinant E. coli strain for production of human growth hormone Danish Medical Bulletin 35(1): 84-91
Skopec, L.L. 1987: Potential risks associated with indoor tanning South Dakota Journal of Medicine 40(3): 31-33
Kang, X.; Liu, Z.; Li, S. 2004: Potential ecological risks of transgenic trees Ying Yong Sheng Tai Xue Bao 15(7): 1281-1284
Kuehn, B.M. 2003: NAS reports on potential risks of animal biotechnology Journal of the American Veterinary Medical Association 222(3): 274-275
Shaya, F.T.; Gu, A. 2005: Assessing potential risks and evaluating expected benefits Managed Care Interface 18(5): 27-30
Crameri, R.; Blaser, K.; Menz, G. 1996: Recombinant allergens and their potential in allergologic diagnosis Pneumologie 50(6): 387-393
Gehler, W.; Weinke, I.; Nehmzow, M. 1981: Early diagnosis of children with developmental risks using psychomotor development tests Kinderarztliche Praxis 49(3): 142-151
Armstrong, D.G.; Liswood, P.J.; Todd, W.F. 1995: Potential risks of accommodative padding in the treatment of neuropathic ulcerations Ostomy/Wound Management 41(7): 44-46; 48-49
Interagency Regul Liaison Group Work Group Risk Assess 1979: Scientific bases for identification of potential carcinogens and estimation of risks Journal of the National Cancer Institute 63(1): 241-268
Bose, W.J. 1996: The potential use of human recombinant erythropoietin in orthopedic surgery Orthopedics 19(4): 325-328
Haedersdal, M. 2005: Potential risks of non-physicians' use of lasers and intense pulsed light in dermatology Ugeskrift for Laeger 167(43): 4095-4097
Caligiuri, M.A. 1993: Low-dose recombinant interleukin-2 therapy: rationale and potential clinical applications Seminars in Oncology 20(6 Suppl 9: 3-10
Butler, A.R.; Smith, J.A.; Polis, C.B.; Gregson, S.; Stanton, D.; Hallett, T.B. 2013: Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk Aids 27(1): 105-113
Steinheider, G. 1988: Recombinant hemopoietic growth factors. Molecular cloning and potential therapeutic applications Arzneimittel-Forschung 38(6): 851-854
Assiri, A.S.; El-Gamal, B.A.; Hafez, E.E.; Haidara, M.A. 2014: Production of recombinant streptokinase from Streptococcus pyogenes isolate and its potential for thrombolytic therapy Saudi Medical Journal 35(12): 1482-1488
Mitsuyasu, R.T. 1989: The enhanced potential use of recombinant alpha interferon in the treatment of AIDS-related Kaposi's sarcoma Oncology Nursing Forum 16(6): 5-7